- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT04872049
Assessment of SARS-CoV-2 Effect on Post-traumatic Stress of Patients Hospitalized in Intensive Care Unit (FAMILY-COVID)
Assessment of SARS-CoV-2 Effect on Post-traumatic Stress of Patients Hospitalized in Intensive Care
Patients admitted to the intensive care unit develop psychiatric disorders, such as anxiety, depression or post-traumatic stress disorder, which can be prolonged.
During the COVID crisis, the presence of relatives in the intensive care unit was reduced and this, in a lasting way.
The hypothesis is that there is a difference in the experience of the stay in the intensive care unit whether or not one is affected by SARS-CoV-2 and that this difference is likely to have an impact on the long-term outcome of the patients and their relatives.
Studieöversikt
Status
Betingelser
Detaljerad beskrivning
The stay in the ICU is a complex and often traumatic experience for patients. Patients often develop psychiatric disorders such as anxiety, depression or post-traumatic stress disorder after an ICU stay. These symptoms can be prolonged over time, resulting in a decrease in quality of life and a potential cost in care.
In the epidemic context of the COVID crisis, the presence of family members in the intensive care unit was reduced to its most extreme portion, with sometimes an almost total impossibility of visiting a loved one. This situation, although it has become less strict, has lasted for a long time. The patient can only exchange with them with difficulty, despite the extremely trying situation that is resuscitation. Moreover, there is a stress factor linked to the infectious risk for the relatives and for the relatives with regard to COVID-19, in particular within the framework of family clusters with sometimes several hospitalized subjects within the same family.
Of course, means of communication have been put in place with relatives, but these means do not seem to be equivalent to the presence of one's relatives.
The investigators therefore hypothesize that there is a difference in the experience of the stay in the intensive care unit whether or not one is affected by SARS-CoV-2 and that this difference is likely to have an impact on the long-term outcome of patients and their relatives.
Studietyp
Inskrivning (Förväntat)
Kontakter och platser
Studieorter
-
-
Ile De France
-
Paris, Ile De France, Frankrike, 75013
- GH Pitié Salpêtrière - Charles Foix
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Beskrivning
Inclusion Criteria:
- Major patients (above 18 years old)
- Admitted in intensive care unit
- Hospitalized more than 2 days (48 hours)
- Between 01/01/2020 and 06/30/2020
- Whether SARS-CoV-2 positive or negative
Exclusion Criteria:
- Minor patient
- Protected major (under safeguardship, curatorship or guardianship)
- Patient opposition
Studieplan
Hur är studien utformad?
Designdetaljer
- Observationsmodeller: Kohort
- Tidsperspektiv: Tvärsnitt
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Prevalence of post-traumatic stress at 1 year
Tidsram: 12 months from hospitalization
|
Prevalence of post-traumatic stress in patients treated in intensive care at 1 year diagnosed with an IES-r> 33 depending on whether they are SARS-CoV-2 positive or not. (IES-r: Impact of Event Scale - Revised scale, minimum value: 0, maximum value: 88, higher score indicates a worse outcome) |
12 months from hospitalization
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Level of depression at 1 year
Tidsram: 12 months from hospitalization
|
Assessed by the Center for Epidemiologic Studies Depression scale (CES-D, minimum value: 0, maximum value: 60, higher score indicates a worse outcome)
|
12 months from hospitalization
|
Perceived interest of the proposed communication tools at 1 year
Tidsram: 12 months from hospitalization
|
Semi-structured interviews
|
12 months from hospitalization
|
Level of quality of life at 1 year
Tidsram: 12 months from hospitalization
|
Assessed by EQ-5D (EuroQol 5Dimension scale, minimum value: 0, maximum value: 100, higher score indicates a better outcome)
|
12 months from hospitalization
|
Samarbetspartners och utredare
Utredare
- Studierektor: Claire FAZILLEAU, Assistance Publique - Hôpitaux de Paris
- Huvudutredare: Arthur Dr JAMES, MD, Assistance Publique - Hôpitaux de Paris
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Förväntat)
Avslutad studie (Förväntat)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Andra studie-ID-nummer
- APHP200450
- 2020-A03430-39 (Annan identifierare: IDRCB)
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på SARS-CoV-2
-
Shanghai PerHum Therapeutics Co., Ltd.Shanghai Zhongshan HospitalRekrytering
-
Poitiers University HospitalOkändGuldstandarden för aktuell SARS CoV2-detektion är RT-PCRFrankrike
-
Centre Hospitalier Universitaire DijonOkänd
-
National Institute of Allergy and Infectious Diseases...Avslutad
-
Hospices Civils de LyonAktiv, inte rekryterandeCoV2 positiva vårdgivareFrankrike
-
Bioaraba Health Research InstituteFundación Eduardo AnituaAvslutadSARS lunginflammation | SARSpanien
-
Collegium Medicum w BydgoszczyRekryteringSARS-CoV2-infektion | SARS-CoV2-antikropparPolen
-
Mayo ClinicNational Institute of Neurological Disorders and Stroke (NINDS)Rekrytering
-
Collegium Medicum w BydgoszczyAktiv, inte rekryterandeSARS-CoV2-infektion | SARS-CoV2-antikropparPolen
-
Anewsha Therapeutics Inc.University of Michigan; Biologics ConsultingHar inte rekryterat ännuCovid-19 | SARFörenta staterna